Histone deacetylase 3 (HDAC3) plays an important role in retinal ganglion cell death after acute optic nerve injury

Molecular Neurodegeneration

Volumn 9, Issue 1, 2014, Pages

  Schmitt, Heather M ^a   Pelzel, Heather R ^b   Schlamp, Cassandra L ^a   Nickells, Robert W ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF WISCONSIN WHITEWATER   (United States)

Author keywords

Apoptosis; Chromatin remodeling; Deacetylation; Epigenetics; HDAC; Heterochromatin; Neuronal degeneration; Retinal ganglion cell

Indexed keywords

CRE RECOMBINASE; HISTONE DEACETYLASE 3; PARVOVIRUS VECTOR; TRICHOSTATIN A; HISTONE DEACETYLASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ATROPHY; AXONAL INJURY; CELL NUCLEUS MEMBRANE; CONTROLLED STUDY; CRUSH TRAUMA; DEACETYLATION; GENE EXPRESSION; GENE INACTIVATION; GENE SILENCING; HETEROCHROMATIN; HISTONE ACETYLATION; MOUSE; NERVE CELL NECROSIS; NONHUMAN; NUCLEAR PORE; OPTIC NERVE; OPTIC NERVE INJURY; PROTEIN FUNCTION; RETINA GANGLION CELL; VIRAL GENE DELIVERY SYSTEM; ANIMAL; C57BL MOUSE; ENZYMOLOGY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; KNOCKOUT MOUSE; MALE; METABOLISM; PATHOLOGY; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; TRANSMISSION ELECTRON MICROSCOPY; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HISTONE DEACETYLASES; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROSCOPY, ELECTRON, TRANSMISSION; OPTIC NERVE INJURIES; REAL-TIME POLYMERASE CHAIN REACTION; RETINAL GANGLION CELLS;

EID: 84907963408     PISSN: None     EISSN: 17501326     Source Type: Journal    
DOI: 10.1186/1750-1326-9-39     Document Type: Article

References (55)

1. Retinal ganglion cell death in glaucoma: the how, the why, and the maybe. Nickells RW, J Glaucoma 1996 5 5 345 356 8897235
2. Retinal ganglion cell death in experimental glaucoma and after axotomy occurs by apoptosis. Quigley HA, Nickells RW, Kerrigan LA, Pease ME, Thibault DJ, Zack DJ, Invest Ophthalmol Vis Sci 1995 36 5 774 786 7706025
3. Structural and functional abnormalities of retinal ganglion cells measured in vivo at the onset of optic nerve head surface change in experimental glaucoma. Fortune B, Burgoyne CF, Cull GA, Reynaud J, Wang L, Invest Ophthalmol Vis Sci 2012 53 7 3939 3950 10.1167/iovs.12-9979 22589428
4. Intraocular pressure magnitude and variability as predictors of rates of structural change in non-human primate experimental glaucoma. Gardiner SK, Fortune B, Wang L, Downs JC, Burgoyne CF, Exp Eye Res 2012 103 1 8 22960316
5. Under pressure: cellular and molecular responses during glaucoma, a common neurodegeneration with axonopathy. Nickells RW, Howell GR, Soto I, John SW, Annu Rev Neurosci 2012 35 153 179 10.1146/annurev.neuro.051508.135728 22524788
6. 'Axogenic' and 'somagenic' neurodegenerative diseases: definitions and therapeutic implications. Schwartz M, Yoles E, Levin LA, Mol Med Today 1999 5 11 470 473 10.1016/S1357-4310(99)01592-0 10529787
7. Optic nerve crush: protection and regeneration. Schwartz M, Brain Res Bull 2004 62 6 467 471 10.1016/S0361-9230(03)00076-5 15036559
8. Nuclear atrophy of retinal ganglion cells precedes the bax-dependent stage of apoptosis. Janssen KT, Mac Nair CE, Dietz JA, Schlamp CL, Nickells RW, Invest Ophthalmol Vis Sci 2013 54 3 1805 1815 10.1167/iovs.11-9310 23422829
9. RGC death in mice after optic nerve crush injury: oxidative stress and neuroprotection. Levkovitch-Verbin H, Harris-Cerruti C, Groner Y, Wheeler LA, Schwartz M, Yoles E, Invest Ophthalmol Vis Sci 2000 41 13 4169 4174 11095611
10. Histone H4 deacetylation plays a critical role in early gene silencing during neuronal apoptosis. Pelzel HR, Schlamp CL, Nickells RW, BMC Neurosci 2010 11 62 10.1186/1471-2202-11-62 20504333
11. Changes in Thy1 gene expression associated with damaged retinal ganglion cells. Schlamp CL, Johnson EC, Li Y, Morrison JC, Nickells RW, Mol Vis 2001 7 192 201 11509915
12. Experimental induction of retinal ganglion cell death in adult mice. Li Y, Schlamp CL, Nickells RW, Invest Ophthalmol Vis Sci 1999 40 5 1004 1008 10102300
13. Bid-induced conformational change of Bax is responsible for mitochondrial cytochrome c release during apoptosis. Desagher S, Osen-Sand A, Nichols A, Eskes R, Montessuit S, Lauper S, Maundrell K, Antonsson B, Martinou JC, J Cell Biol 1999 144 5 891 901 10.1083/jcb.144.5.891 10085289
14. Caspases: cellular demolition experts. Creagh EM, Martin SJ, Biochem Soc Trans 2001 29 Pt 6 696 702 11709057
15. Mitochondrial involvement in the point of no return in neuronal apoptosis. Chang LK, Putcha GV, Deshmukh M, Johnson EM Jr, Biochimie 2002 84 2-3 223 231 12022953
16. Silencing of Fem1cR3 gene expression in the DBA/2 J mouse precedes retinal ganglion cell death and is associated with histone deacetylase activity. Pelzel HR, Schlamp CL, Waclawski M, Shaw MK, Nickells RW, Invest Ophthalmol Vis Sci 2012 53 3 1428 1435 10.1167/iovs.11-8872 22297488
17. Microarray analysis of changes in mRNA levels in the rat retina after experimental elevation of intraocular pressure. Ahmed F, Brown KM, Stephan DA, Morrison JC, Johnson EC, Tomarev SI, Invest Ophthalmol Vis Sci 2004 45 4 1247 1258 10.1167/iovs.03-1123 15037594
18. Incipient Alzheimer's disease: microarray correlation analyses reveal major transcriptional and tumor suppressor responses. Blalock EM, Geddes JW, Chen KC, Porter NM, Markesbery WR, Landfield PW, Proc Natl Acad Sci U S A 2004 101 7 2173 2178 10.1073/pnas.0308512100 14769913
19. Transcriptional dysregulation in Huntington's disease. Cha JH, Trends Neurosci 2000 23 9 387 392 10.1016/S0166-2236(00)01609-X 10941183
20. Polyglutamine-expanded ataxin-3 causes cerebellar dysfunction of SCA3 transgenic mice by inducing transcriptional dysregulation. Chou AH, Yeh TH, Ouyang P, Chen YL, Chen SY, Wang HL, Neurobiol Dis 2008 31 1 89 101 10.1016/j.nbd.2008.03.011 18502140
21. The medial and lateral substantia nigra in Parkinson's disease: mRNA profiles associated with higher brain tissue vulnerability. Duke DC, Moran LB, Pearce RK, Graeber MB, Neurogenetics 2007 8 2 83 94 10.1007/s10048-006-0077-6 17211632
22. Microarray analysis of the cellular pathways involved in the adaptation to and progression of motor neuron injury in the SOD1 G93A mouse model of familial ALS. Ferraiuolo L, Heath PR, Holden H, Kasher P, Kirby J, Shaw PJ, J Neurosci 2007 27 34 9201 9219 10.1523/JNEUROSCI.1470-07.2007 17715356
23. Retinal ganglion cells downregulate gene expression and lose their axons within the optic nerve head in a mouse glaucoma model. Soto I, Oglesby E, Buckingham BP, Son JL, Roberson ED, Steele MR, Inman DM, Vetter ML, Horner PJ, Marsh-Armstrong N, J Neurosci 2008 28 2 548 561 10.1523/JNEUROSCI.3714-07.2008 18184797
24. Transcriptional abnormalities in Huntington disease. Sugars KL, Rubinsztein DC, Trends Genet 2003 19 5 233 238 10.1016/S0168-9525(03)00074-X 12711212
25. Changes in gene expression in experimental glaucoma and optic nerve transection: the equilibrium between protective and detrimental mechanisms. Yang Z, Quigley HA, Pease ME, Yang Y, Qian J, Valenta D, Zack DJ, Invest Ophthalmol Vis Sci 2007 48 12 5539 5548 10.1167/iovs.07-0542 18055803
26. Full-length axon regeneration in the adult mouse optic nerve and partial recovery of simple visual behaviors. de Lima S, Koriyama Y, Kurimoto T, Oliveira JT, Yin Y, Li Y, Gilbert HY, Fagiolini M, Martinez AM, Benowitz L, Proc Natl Acad Sci U S A 2012 109 23 9149 9154 10.1073/pnas.1119449109 22615390
27. Enhancing the apoptotic and therapeutic effects of HDAC inhibitors. Frew AJ, Johnstone RW, Bolden JE, Cancer Lett 2009 280 2 125 133 10.1016/j.canlet.2009.02.042 19359091
28. Selective toxicity by HDAC3 in neurons: regulation by Akt and GSK3beta. Bardai FH, D'Mello SR, J Neurosci 2011 31 5 1746 1751 10.1523/JNEUROSCI.5704-10.2011 21289184
29. Matters of life and death: the role of chromatin remodeling proteins in retinal neuron survival. Lagali PS, Picketts DJ, J Ocul Biol Dis Infor 2011 4 3 111 120 10.1007/s12177-012-9080-3 23289056
30. Inhibition of HDAC2 protects the retina from ischemic injury. Fan J, Alsarraf O, Dahrouj M, Platt KA, Chou CJ, Rice DS, Crosson CE, Invest Ophthalmol Vis Sci 2013 54 6 4072 4080 10.1167/iovs.12-11529 23696608
31. Histone deacetylase-3 interacts with ataxin-7 and is altered in a spinocerebellar ataxia type 7 mouse model. Duncan CE, An MC, Papanikolaou T, Rugani C, Vitelli C, Ellerby LM, Mol Neurodegener 2013 8 1 42 10.1186/1750-1326-8-42 24160175
32. HDAC3 and the molecular brake pad hypothesis. McQuown SC, Wood MA, Neurobiol Learn Mem 2011 96 1 27 34 10.1016/j.nlm.2011.04.005 21521655
33. Cellular tropism and transduction properties of seven adeno-associated viral vector serotypes in adult retina after intravitreal injection. Hellstrom M, Ruitenberg MJ, Pollett MA, Ehlert EM, Twisk J, Verhaagen J, Harvey AR, Gene Ther 2009 16 4 521 532 10.1038/gt.2008.178 19092858
34. Evaluation of the percentage of ganglion cells in the ganglion cell layer of the rodent retina. Schlamp CL, Montgomery AD, Mac Nair CE, Schuart C, Willmer DJ, Nickells RW, Mol Vis 2013 19 1387 1396 23825918
35. Immunopanning purification and long-term culture of human retinal ganglion cells. Zhang XM, Li Liu DT, Chiang SW, Choy KW, Pang CP, Lam DS, Yam GH, Mol Vis 2010 16 2867 2872 21203402
36. Inhibition of histone deacetylase protects the retina from ischemic injury. Crosson CE, Mani SK, Husain S, Alsarraf O, Menick DR, Invest Ophthalmol Vis Sci 2010 51 7 3639 3645 10.1167/iovs.09-4538 20164449
37. Histone deacetylase inhibitors sodium butyrate and valproic acid delay spontaneous cell death in purified rat retinal ganglion cells. Biermann J, Boyle J, Pielen A, Lagreze WA, Mol Vis 2011 17 395 403 21311741
38. Valproic acid-mediated neuroprotection and regeneration in injured retinal ganglion cells. Biermann J, Grieshaber P, Goebel U, Martin G, Thanos S, Di Giovanni S, Lagreze WA, Invest Ophthalmol Vis Sci 2010 51 1 526 534 10.1167/iovs.09-3903 19628741
39. Inhibition of histone deacetylases 1 and 3 protects injured retinal ganglion cells. Chindasub P, Lindsey JD, Duong-Polk K, Leung CK, Weinreb RN, Invest Ophthalmol Vis Sci 2013 54 1 96 102 10.1167/iovs.12-10850 23197683
40. Disassociation of histone deacetylase-3 from normal huntingtin underlies mutant huntingtin neurotoxicity. Bardai FH, Verma P, Smith C, Rawat V, Wang L, D'Mello SR, J Neurosci 2013 33 29 11833 11838 10.1523/JNEUROSCI.5831-12.2013 23864673
41. Chemical probes identify a role for histone deacetylase 3 in Friedreich's ataxia gene silencing. Xu C, Soragni E, Chou CJ, Herman D, Plasterer HL, Rusche JR, Gottesfeld JM, Chem Biol 2009 16 9 980 989 10.1016/j.chembiol.2009.07.010 19778726
42. Deficiency in Bim, Bid and Bbc3 (Puma) do not prevent axonal injury induced death. Harder JM, Libby RT, Cell Death Differ 2013 20 1 182 10.1038/cdd.2012.119 22996683
43. Role of histone deacetylases in gene regulation at nuclear lamina. Milon BC, Cheng H, Tselebrovsky MV, Lavrov SA, Nenasheva VV, Mikhaleva EA, Shevelyov YY, Nurminsky DI, PLoS One 2012 7 11 49692 10.1371/journal.pone.0049692 23226217
44. A single nucleotide polymorphism in the Bax gene promoter affects transcription and influences retinal ganglion cell death. Semaan SJ, Li Y, Nickells RW, ASN Neuro 2010 2 2 00032 20360947
45. Distinct p53 acetylation cassettes differentially influence gene-expression patterns and cell fate. Knights CD, Catania J, Di Giovanni S, Muratoglu S, Perez R, Swartzbeck A, Quong AA, Zhang X, Beerman T, Pestell RG, Avantaggiati ML, J Cell Biol 2006 173 4 533 44 10.1083/jcb.200512059 16717128
46. Acetylation of mouse p53 at lysine 317 negatively regulates p53 apoptotic activities after DNA damage. Chao C, Wu Z, Mazur SJ, Borges H, Rossi M, Lin T, Wang JY, Anderson CW, Appella E, Xu Y, Mol Cell Biol 2006 26 18 6859 6869 10.1128/MCB.00062-06 16943427
47. Specific acetylation of p53 by HDAC inhibition prevents DNA damage-induced apoptosis in neurons. Brochier C, Dennis G, Rivieccio MA, McLaughlin K, Coppola G, Ratan RR, Langley B, J Neurosci 2013 33 20 8621 8632 10.1523/JNEUROSCI.5214-12.2013 23678107
48. Studies of benzamide- and thiol-based histone deacetylase inhibitors in models of oxidative-stress-induced neuronal death: identification of some HDAC3-selective inhibitors. Chen Y, He R, Chen Y, D'Annibale MA, Langley B, Kozikowski AP, ChemMedChem 2009 4 5 842 852 10.1002/cmdc.200800461 19350613
49. Dynamic distribution of HDAC1 and HDAC2 during mitosis: association with F-actin. He S, Khan DH, Winter S, Seiser C, Davie JR, J Cell Physiol 2013 228 7 1525 1535 10.1002/jcp.24311 23280436
50. Gene expression, chromosome position and lamin A/C mutations. Puckelwartz MJ, Depreux FF, McNally EM, Nucleus 2011 2 3 162 167 10.4161/nucl.2.3.16003 21818408
51. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Kerr JF, Wyllie AH, Currie AR, Br J Cancer 1972 26 4 239 257 10.1038/bjc.1972.33 4561027
52. Shrinkage necrosis: a distinct mode of cellular death. Kerr JF, J Pathol 1971 105 1 13 20 10.1002/path.1711050103 4108566
53. Hdac3 is essential for the maintenance of chromatin structure and genome stability. Bhaskara S, Knutson SK, Jiang G, Chandrasekharan MB, Wilson AJ, Zheng S, Yenamandra A, Locke K, Yuan JL, Bonine-Summers AR, Wells CE, Kaiser JF, Washington MK, Zhao Z, Wagner FF, Sun ZW, Xia F, Holson EB, Khabele D, Hiebert SW, Cancer Cell 2010 18 5 436 447 10.1016/j.ccr.2010.10.022 21075309
54. Dominant inheritance of retinal ganglion cell resistance to optic nerve crush in mice. Li Y, Semaan SJ, Schlamp CL, Nickells RW, BMC Neurosci 2007 8 19 10.1186/1471-2202-8-19 17338819
55. Rapid amplification of complementary DNA from small amounts of unfractionated RNA. Doherty PJ, Huesca-Contreras M, Dosch HM, Pan S, Anal Biochem 1989 177 1 7 10 10.1016/0003-2697(89)90003-1 2472758